The objective of this project is to determine the feasibility of introducing CGMs to adolescent patients with obesity and pre-diabetes (Hemoglobin A1C: HbA1C between 5.7-6.5%) to determine whether their eating habits and subsequent glucose profiles are modified by the timely awareness of glucose excursions above the diabetes threshold of 200 mg/dl.
Children aged 13-17 years.
BMI ≥ 95 percentile
Race/ethnicity Native American, African American, Latino, Asian American, Pacific Islander
Signs of insulin resistance or conditions associated with insulin resistance (acanthosis nigricans, hypertension, dyslipidemia, polycystic ovary syndrome, or small-for-gestational-age birth weight)
Diabetes by history or HbA1c ≥ 6.5 % in the medical record or at screening.
Unable or unwilling to provide consent or participate fully in study activities.
Conditions predisposing to diabetes or altering normal pubertal development.
Known syndromic or monogenic obesity.
University of Florida
Lead sponsor
Healthcare Network
Collaborator
Collier County Health Services
Collaborator